FDA NDC Directory · JSON-LD · Markdown

Thalomid

NDC 59572-215 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameThalidomide
Labeler / ManufacturerCelgene Corporation
Marketing categoryNew Drug Application (innovator) · App NDA020785
Dosage form / routeCAPSULE · ORAL
Active ingredientsTHALIDOMIDE (150 mg/1)
Marketing started20070320
Package count1

External sources

Source: openFDA. Public-domain (CC0).